Guy Van Camp

Professor

University of Antwerp

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Cancer Biology Cancer Biology professors in Belgium

Contact this professor

ORCID

Google Scholar

About

Guy Van Camp is a Professor at the University of Antwerp in Belgium. His research primarily focuses on cancer genomics, with recent articles exploring topics such as circulating tumor DNA detection, the implications of DNA methylation in liver disease, and the molecular characteristics of non-small cell lung cancer. He has contributed to understanding HPV types associated with cervical cancer and the impact of genetic mutations on cancer treatment sensitivity.

Guy Van Camp

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration

Circulating Tumor DNA detection in cancer: a comprehensive overview of current detection methods and prospects

Lineages and sublineages of high-risk human papillomavirus types associated with cervical cancer and precancer: a systematic review and meta-analysis

Exploring the conformational space of ROS1 kinase domain and the impact of allosteric mutations.

Simultaneous detection of eight cancer types using a multiplex droplet digital PCR assay

Genome-wide DNA methylation analysis reveals a unique methylation pattern for pleural mesothelioma compared to healthy pleura and other lung diseases.

Transcriptomic analysis of &lt;i&gt;ROS1&lt;/i&gt;+ non-small cell lung cancer reveals an upregulation of nucleotide synthesis and cell adhesion pathways.

Clinicopathological and molecular differences between stage IV screen-detected and interval colorectal cancers in the Flemish screening program

CRISPR/Cas9-edited <i>ROS1</i> + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles

CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles

New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer

Genetic Evaluation of Prelingual Hearing Impairment: Recommendations of an European Network for Genetic Hearing Impairment

Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives

The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective

Targeted Resequencing of Otosclerosis Patients from Different Populations Replicates Results from a Previous Genome-Wide Association Study

Genetics of otosclerosis: finally catching up with other complex traits?

Genetics of otosclerosis: finally catching up with other complex traits?

A wide range of protective and predisposing variants in aggrecan influence the susceptibility for otosclerosis

Genome-wide DNA methylation profiling and identification of potential pan-cancer and tumor-specific biomarkers

Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up

Antiproliferative, Antiangiogenic, and Antimetastatic Therapy Response by Mangiferin in a Syngeneic Immunocompetent Colorectal Cancer Mouse Model Involves Changes in Mitochondrial Energy Metabolism

Collaborators (18)

Anne-Francoise Roux

Wim Van Hul

MIGUEL ANGEL MORENO-PELAYO

Erik Fransen

Dominika Oziębło

Silvia Dossena

Isabelle Schrauwen

Helena Caria

Steven Van Laere

Giorgia Girotto

Marc Peeters

Joe Ibrahim

An Boudewyns

Hans Prenen

Alessandro Martini

Sebastian Roesch

Saba Battelino

Katarina Trebušak Podkrajšek

How do I reach out?

Meet Kite AI

Transcriptomic analysis of <i>ROS1</i>+ non-small cell lung cancer reveals an upregulation of nucleotide synthesis and cell adhesion pathways.